Mark Reynolds
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $727, 7.4 times the $98 reported in 2021.
Across 119 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$417
- AbbVie$312
- Pfizer$254
- Boehringer Ingelheim$207
- Lilly USA, LLC$184
- Verona Pharma, Inc.$147
- plus $877 from 19 others
What the payments were for
- Food & beverage$2,33197%
- Education$663%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $417 |
| AbbVie | 18 | $312 |
| Pfizer | 11 | $254 |
| Boehringer Ingelheim | 11 | $207 |
| Lilly USA, LLC | 8 | $184 |
| Verona Pharma, Inc. | 9 | $147 |
| Novo Nordisk | 10 | $136 |
| Astellas Pharma US Inc | 3 | $101 |
| GSK | 3 | $99 |
| Amgen | 6 | $87 |
| Novartis | 4 | $72 |
| Merck | 3 | $52 |
| Inari Medical, Inc. | 1 | $44 |
| Dexcom, Inc. | 2 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Bayer | 2 | $32 |
| Medtronic | 2 | $29 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Stryker | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Dynavax Technologies Corporation | 1 | $14 |
How this compares
$2,397 in reported general payments places this provider in the 80th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 79 | $748 |
| Azithromycin | 100 | $338 |
| Fluconazole | 51 | $241 |
| Prednisone | 193 | $229 |
| Ondansetron OdtOndansetron | 17 | $164 |
| Cephalexin | 41 | $142 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $124 |
| Ciprofloxacin Hcl | 22 | $118 |
| Amoxicillin | 26 | $94 |
| Cyclobenzaprine Hcl | 13 | $54 |
| Naproxen | 24 | $43 |
| Meclizine Hcl | 11 | $42 |
| Methylprednisolone | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other family in Union
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
- Hailey AtkinsonIrmo$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.